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Much attention has been focused on the manner in which tumour cells die after treatment with cytotoxic agents. The basic question
is whether cells die via apoptosis or via direct damage from the toxic agent. Various assays have been used to make this distinction.
However, we show herein that some of the widely used assays for apoptosis do not in fact distinguish between apoptosis and other
forms of cell death. More specifically: (1) A sub-G1 DNA content, identified by propidium iodide staining, does not distinguish
between apoptotic and necrotic cells; (2) loss of mitochondrial membrane potential does not distinguish between apoptotic and
necrotic cells, unless combined with an assay for an intact cell membrane; (3) subcellular fragments that arise from dead cells or from
apoptotic bodies can interfere with some assays for apoptosis such as annexin V staining, as they may be close to the size of intact
cells, making it difficult to decide where to set the size threshold; (4) irradiated cells display a large increase in nonspecific Ab binding.
This may be partly due to an increase in cell size, but, regardless of the cause, it can lead to a mistaken conclusion that there is an
increase in a particular antigen if appropriate control reagents are not tested; and (5) experiments utilising Ab crosslinking have
neglected the role of cell aggregation, which can cause multiple problems including death from mechanical stress when cells are
handled. Consideration of these factors will improve our ability to determine the mode of cell death.
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In the continuing attempt to destroy tumour cells while preserving
the life of the animal, it is important to understand the mechanism
of cell death that is induced by various toxic agents. In recent
years, the idea that tumour cells treated with cytotoxic drugs or
radiation die owing to apoptosis (programmed cell death), as
opposed to the direct effect of the treatment itself, has become
widely accepted (Barry et al, 1990; Reed et al, 1994; Aldridge and
Radford, 1998; Ferreira et al, 2002; Jazirehi et al, 2003; Okada and
Mak, 2004). There are, however, a few persuasive skeptics (Brown
and Wouters, 1999; Steel, 2001; Gerl and Vaux, 2005). We have
begun to investigate the mechanism of cell death induced by
radiolabelled antibodies (Abs), primarily using radionuclides
emitting low-energy electrons (some Auger and conversion
electrons) (Griffiths et al, 1999; Ong et al, 2001). Unexpectedly,
we found that some of the assays widely used to detect apoptosis
do not distinguish between apoptosis and other forms of cell death.
The purpose of this paper is to describe five of the problems that
have been identified. As apoptosis consists of a cascade of
biochemical steps, any of these steps can be monitored as a
measure of apoptosis. A large number of such assays have been
used and most of them are reliable. However, (1) cells having sub-
G1 DNA content have been assumed to be apoptotic (Chan et al,
2003; Jazirehi et al, 2003), but various types of cell fragments also
may have a sub-G1 DNA content, and we demonstrate herein that
three types of necrotic cell preparations have large numbers of
cells with sub-G1 DNA; (2) similarly, although apoptotic cells lose
mitochondrial membrane potential (Darzynkiewicz et al, 2001)
and although the mitochondrial membrane is a major focus of
apoptotic pathways (Green, 2003; Henry-Mowatt et al, 2004), we
show that necrotic cells also lose mitochondrial membrane
potential; (3) subcellular fragments can potentially interfere with
assays such as annexin V staining. Apoptosis and other types of
cell death usually generate subcellular fragments, and these may be
mistaken for apoptotic cells; (4) cell damage owing to irradiation
causes an increase in nonspecific Ab binding (to viable, non-
apoptotic cells), which can lead to false conclusions regarding
Ab specificity if negative control Abs are not tested; and (5) Ab
binding can induce tight aggregation of cells, especially if a
secondary Ab is included. Such aggregates are sometimes
impossible to disperse by the usual methods, without killing the
cells, and therefore these cells cannot be evaluated for apoptosis, or
any other property, by many of the commonly used methods.
These results are not meant to imply that apoptosis is not the
mode of cell death in many situations, for both normal and tumour
cells. Some new anticancer drugs are specifically designed to
activate apoptosis, and probably act via this mechanism (Gerl and
Vaux, 2005). However, in regard to classical cytotoxic drugs and
radiation, some re-evaluation of the literature, based on the factors
described herein, may be required in order to correctly understand
the mechanism of cell death.
MATERIALS AND METHODS
Cell lines, Abs, and other reagents
The Jurkat T-lymphoma and Ramos and Raji B-lymphoma cell
lines were obtained from the American Type Culture Collection
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s(Manassas, VA, USA). They were grown in RPMI 1640 medium
containing 12.5% foetal bovine serum and supplemented with
glutamine and penicillin/streptomycin (Invitrogen, Grand, Island,
NY, USA). Cells were tested routinely for mycoplasma by the
Mycotect assay (Invitrogen) and were negative. Antibody L243 is
an IgG2a Ab to HLA-DR, and was produced by the hybridoma
obtained from ATCC, as described previously (Ong et al, 2001).
Annexin V conjugated to Alexa 488 was from Molecular Probes
(Eugene, OR, USA). Digitonin was from Sigma Chemicals (St
Louis, MO, USA, #37006) and other drugs and chemicals were also
from Sigma.
Induction of necrosis or apoptosis
Stock etoposide (Sigma Chemicals, #E-1383,¼VP-16) was 100mM
in DMSO (dimethylsulfoxide) and was stored at  201C. It was used
at a final concentration of 30mM (Amarante-Mendes et al, 1998),
and was incubated with cells for 16–18h under standard tissue
culture conditions. Stock camptothecin (CTT, Sigma #C-9911) was
10mM in DMSO, also stored at  201C. It was used at a final
concentration of 4mM (Johnson et al, 1997), and was incubated
with cells for 4h. Stock paclitaxel (the pharmaceutical from Mead
Johnson, Princeton, NJ, USA) was at 6mgml
 1, as supplied, and
stored at room temperature. It was used at a final concentration of
40nM (Jazirehi et al, 2003) and was incubated with cells for 18–
20h. For the drugs dissolved initially in DMSO, DMSO alone at the
same concentration was tested as a control: this always had very
little or no effect. Heat treatment was at 561C for 45min, which was
the minimum time required to kill all of the cells, as assayed by
trypan blue exclusion. Cells were heated in tissue culture medium,
then diluted and plated under normal tissue culture conditions.
Treatment with digitonin was at 0.005% for 5min. The digitonin
was dissolved by heating at 1001C for 3min in water at a
concentration of 1.0% just before use. It was diluted 1:5 in
phosphate-buffered saline (PBS), then diluted 1:40 to the cell
suspension, which was in sterile Dulbecco’s phosphate-buffered
saline (DPBS) (Invitrogen), 0.5% bovine albumin, and 10mM
NaN3. To kill cells by freeze–thawing, cells in 1.0ml tissue culture
medium were snap-frozen in 2-methyl-butane, cooled with dry ice
and then thawed at 371C. This killed more than 90% of the cells.
Cells were irradiated with a
137Cs irradiator (JL Sheppard, San
Fernando, CA, USA) at the University of Medicine and Dentistry of
New Jersey (Newark, NJ, USA). The time required to deliver 10Gy
was approximately 7min.
PI staining of DNA content
Cells were washed once with tissue culture medium without phenol
red and then suspended in 0.5ml of 0.1% sodium citrate (3.4mM)
and 0.1% Triton X-100 containing 50mgml
 1 propidium iodide
(PI) (Nicoletti et al, 1991). Analysis was with a FACSCalibur (BD
Biosciences, San Jose, CA, USA).
JC-1 staining of mitochondria
JC-1 (Sigma) was dissolved at 1.0% in DMSO and stored at  201C.
A 1/100 volume was added to approximately 5 10
5 cells in
approximately 130ml of tissue culture medium. After 10min at
371C, cells were washed twice with tissue culture medium, the
second time without phenol red, then suspended in 0.5ml for
fluorescence-activated cell sorter (FACS) analysis. This assay
produced results identical to the Mitoscreen assay of BD
Biosciences (San Diego, CA, USA). The nuclear stain Sytox green
was obtained from Molecular Probes at 5mM in DMSO and stored
at  201C. The stock was prepared by diluting 2ml into 1.0ml tissue
culture medium without phenol red, and 1/100 volume of this was
added to the cell suspension. After 5min at room temperature,
samples were analyzed on a FACSCalibur and were also examined
on an Olympus BH2 fluorescent microscope with a 100W mercury
bulb.
Annexin V staining
Cells were washed once with tissue culture medium without phenol
red supplemented with 2mM CaCl2. After discarding the super-
natant, 5ml of the annexin V conjugate was added to the residual
volume (approximately 130ml). After 45min at room temperature,
cells were washed twice, then suspended in the same medium
containing 1mgml
 1 PI.
Immunofluorescent staining
Cells were stained either with or without fixation and permeabi-
lisation. Unfixed cells were stained in DPBS (Invitrogen), 0.5%
bovine albumin, and 10mM NaN3. Fixed and permeabilised cells
were stained following methods developed to detect cleaved
poly(ADP-ribose) polymerase (PARP) (an intracellular antigen),
although in this study we show only results of nonspecific staining.
Cells were fixed with 4% formaldehyde (prepared from depoly-
merised paraformaldehype; Farr and Nakane, 1981) in PBS with
0.15% saponin (Sigma Chemicals) for 20min at 41C. All buffers
used subsequently also contained 0.15% saponin. After washing,
the pelleted cells were suspended in the residual volume in the tube
(approximately 130ml) and 10mg of the Ab was added in a small
volume (o5ml). The Abs used were either FITC-goat anti-mouse
IgG (Cappell Laboratories, now ICN, Irvine, CA, USA) or FITC-
normal goat IgG F(ab0)2 fragment (Jackson ImmunoResearch,
West Grove, PA, USA). Cells were incubated for 30min usually at
room temperature, washed twice, then examined on a FACSCalibur
and a fluorescent microscope.
Analysis of Ab-induced cell aggregation
Abs were added at the indicated concentrations and cells were then
incubated under tissue culture conditions in a 24-well plate. The
standard method of harvesting the cells, which caused dispersal
of loose aggregates, was to repipette eight times with a short (6
inches) Pasteur pipette. To remove unbound Ab after 24h, from
cells aggregated by L243 without damaging the cells, the cells were
gently transferred to a 15ml tube using a truncated pipettor tip
(with a large opening). The cell aggregates were spun gently (1min,
400 G) and washed four times with 12ml of tissue culture
medium. They were then transferred to a T25 flask containing
20ml medium and incubated for 10 days until they had multiplied
16-fold. Accurate cell counts of aggregated cells could not be
obtained until the aggregates had dispersed, which required
approximately 8 days. The fraction surviving was calculated from
the growth curves as described previously (Griffiths et al, 1999).
Work with 1F5 generally followed Shan et al (1998). Cells
(2.5 10
5 ) were incubated in a 24-well plate in 0.5ml of tissue
culture medium containing 1F5 at 10mgml
 1 for 20min at 371C,
then a secondary Ab, goat anti-mouse IgG Fcg, F(ab0)2 fragment
(Jackson ImmunoResearch) was added to a final concentration of
50mgml
 1, and the incubation continued overnight.
RESULTS
Sub-G1 DNA content, assayed by staining with PI
Necrotic cells were produced by two methods that have been used
by others for this purpose: treatment with heat (Rubartelli et al,
1997) or the mild detergent digitonin (Single et al, 1998). They
were also produced by freeze–thawing. In all three cases, a sub-G1
DNA peak was seen corresponding to fragmented cells (Figure 1).
This effect was not observed immediately after heat treatment or
freeze–thawing even though the cells were virtually all dead at this
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stime, as assessed by trypan blue staining (Figure 1B and G). But
when these killed cells were incubated for 1–3 days at 371C, a large
sub-G1 fraction appeared (Figure 1C,D and H), which can be
attributed to gradual disintegration of the dead cells. Freeze–
thawing caused some aggregation of the cells at time 0 (Figure 1G),
but these aggregates appeared to disperse by the later time points
(Figure 1H). Morphologically, after trypan blue staining, freeze–
thawed cells showed gradual disintegration, but there were no
evident changes in the heat-killed cells. These results are
potentially dependent on the setting of the threshold, which is
the cutoff that separates cells from subcellular debris, based on the
size of the particles. This is a major issue in assays of apoptosis
or other types of cell death, as dead or apoptotic cells commonly
generate subcellular fragments and a single cell can generate
multiple fragments (see the section on annexin V staining below.)
As apoptotic cells are sometimes condensed relative to normal
cells, the threshold cannot be set based on the size of normal cells.
In most of the data shown, we used a threshold of approximately
1/2 the size of the smallest normal (untreated) cell, which was
chosen to reduce the possibility that a single cell could generate
multiple fragments that would be counted as cells. However, this is
not entirely satisfactory, as normal cells vary in size by approxi-
mately twofold (in terms of forward scatter on the FACS). To assess
the impact of this factor, we determined how much the results would
be affected by different threshold settings. Figure 1E shows that with
a threshold set to the size of the smallest normal cells, which is the
highest reasonable setting, there was still a large sub-G1 fraction in
the heat-killed cells that had been incubated for 2 days, and similar
results were obtained with the freeze–thawed cells.
With cells killed by digitonin, also (another way of inducing
necrosis), a large sub-G1 fraction was present (Figure 1F). After a
5min incubation with 0.005% digitonin, virtually all of the cells
were lysed, as determined by trypan blue staining. When assayed
for DNA content, a sub-G1 DNA peak was evident immediately
after digitonin treatment: at time 0, the percentage of cells with a
sub-G1 DNA content was 24.5%. This value increased during a 6h
incubation in tissue culture medium at 371C to 39.2% (Figure 1F
shows results at the 6h time point). We conclude that necrotic cells
can have a sub-G1 DNA content and therefore, this assay cannot
distinguish between apoptotic and necrotic cells.
Mitochondrial membrane potential assayed by JC-1
staining
Jurkat cells lysed by heating at 561C lost all bright red
mitochondria staining from JC-1, as observed by FACS
(Figure 2I) and by microscope. Similar results were obtained with
cells killed by freeze–thawing (data not shown). Control cells had
the expected bright red mitochondrial staining (Figure 2A).
Therefore, these necrotic cells would be mistakenly considered
apoptotic, according to the standard JC-1 staining protocol. We
conclude that this assay also does not distinguish between
apoptotic and necrotic cells. We attempted to distinguish between
lysed and apoptotic cells by adding a nuclear stain, Sytox green, for
dead cells. Although JC-1 also produces green staining in regions
in which it is less concentrated than in healthy mitochondria, the
staining of dead cells by Sytox green was much brighter at the
concentrations used. To demonstrate the value of combining Sytox
green with JC-1 staining, we examined Jurkat cells treated with
100mM etoposide, a standard model for apoptosis. At the time
point examined, 18h, both apoptotic and lysed cells were present.
By visible light microscopy, there were approximately 25% dead
cells (stained with trypan blue) and 30% apoptotic cells (unstained
with trypan blue and abnormal morphologically, many having a
condensed, fragmented nucleus). As shown in Figure 2C, JC-1
staining alone did not distinguish between apoptotic and necrotic
cells, both of which had reduced red staining and would therefore
be considered to be in the ‘apoptotic’ region of the dot plot. But
when Sytox green was included, lysed and apoptotic cells were
clearly distinguished (Figure 2D). The apoptotic cells consisted of
two distinct populations, which can be considered early and late
apoptotic cells, based on their loss of red fluorescence, and cells
intermediate between these two populations were also evident. In
this context, we refer to ‘late’ apoptotic cells as those which have
lost essentially all red mitochondrial staining by JC-1, but still have
an intact plasma membrane, so are not stained by Sytox green.
Note that apoptotic cells had brighter green staining than normal
cells, as well as diminished red staining, and that the green staining
was entirely due to JC-1, not Sytox green, as shown by comparing
Figure 2C and D. Similar results were obtained with another
apoptosis model, Ramos B-lymphoma cells treated overnight with
40nM paclitaxel (Figure 2G and H). Application of the Sytox green
method to heat-killed Jurkat cells demonstrated that all of the
cells were in the ‘lysed cell’ region of the dot plot (Figure 2J), as
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Figure 1 Necrotic cells can have sub-G1 DNA content. Histograms of
cells stained with propidium iodide, a DNA stain, are shown. (A) Control
Jurkat cells. (B–E) Jurkat cells were killed by heating at 561C and analyzed
immediately after killing (B), or after incubation at 371C for 24h (C)o r
48h (D). (E) is the same as (D), except with a higher threshold setting,
which excludes all cells smaller than the smallest normal cell. (F) Jurkat cells
were killed by treatment with 0.005% digitonin for 5min, then washed, and
incubated for 6h at room temperature. (G, H) Jurkat cells were killed by
freeze–thawing and analyzed immediately after killing (G), or after
incubation at 371C for 3 days (H). The bar shows the region considered
to represent cells with sub-G1 DNA content and the percentage of cells
within this region is shown.
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sexpected as all of the cells stained with trypan blue. Thus, this
method correctly identified lysed cells, and distinguished them
from apoptotic cells. In conclusion, necrotic cells would be
misidentified as apoptotic cells by the conventional JC-1 assay,
but are correctly characterised if Sytox green is included.
Annexin V staining and the problem of subcellular
fragments
Unlike the two previous methods, staining with Alexa 488 annexin
V together with PI gave excellent differentiation between lysed
cells, apoptotic cells, and normal cells, when applied to all of the
apoptotic or heat-killed populations described above. Annexin V
reacts with phospholipids that are normally on the inner face of
the cell membrane, but move to the outer face in apoptotic or
necrotic cells (Ran et al, 2005). Like the modified JC-1 assay, this
assay identifies lysed cells by using a dead cell-specific nuclear
stain, in this case PI. However, a significant problem with the assay
is the presence of green (annexin-stained) subcellular fragments.
Small subcellular material is routinely gated out in FACS analysis
by size (measured by forward scatter), but the problem is that
the ‘apoptotic cells’ (annexin V positive, PI negative) formed a
continuum, ranging from the size of normal cells to small vesicles
that are clearly subcellular, with no natural separation between the
two. This is shown in Figure 3, with Jurkat cells treated with 4mM
CTT for 4h. Figure 3A shows representative examples of cells or
cell fragments of various sizes. The annexin V-stained objects
ranged in diameter from the size of normal Jurkat cells
(11.071.0mM) to 3.8mM. Some were stained in a patchy pattern
and others had very homogeneous membrane staining, as shown.
There was a tendency for smaller objects to more commonly have
the homogeneous staining pattern, although the staining pattern
was not strictly correlated with the size of the objects. Figures B
and C show the typical display of apoptotic cells using a dot plot of
FL2 (red) vs FL1 (green). Although the induction of apoptotic cells
by CTT is clear, the calculation of the % apoptotic cells strongly
depends on the size of the objects that are included in the count.
To illustrate this problem, Figure D shows forward scatter vs FL1
for the same cells using the colour scheme from Figure 3C. These
results demonstrate that ‘apoptotic cells’ are smaller than normal
cells, and that many are sufficiently small that they must be
considered subcellular. Figure 3E shows a similar plot of forward
scatter vs side scatter, further demonstrating the relationship
between normal cells and ‘apoptotic cells’. We generally use a
cutoff equal to half the size of the smallest healthy cell (as judged
by the forward scatter, which is proportional to cell size). With this
cutoff (at a value of 145) the % apoptosis was calculated to be
21.6%. However, if the cutoff used was just below the size of the
smallest normal cell (at a value of 290), which is also reasonable,
then the calculated % apoptosis would be only 13.8%, which
represents a reduction of 36%. As the cutoff size is arbitrary, the
calculated % apoptosis is also arbitrary. These data do demon-
strate the induction of apoptosis by CTT, as some of the annexin
V-positive, PI-negative objects were cell size, but there is
considerable uncertainty regarding the % apoptotic cells, as
normally calculated.
Staining for cleaved PARP: nonspecific staining
In investigating the cleavage of PARP by immunofluorescence, we
noted that irradiated but not control cells had quite strong
nonspecific staining with the second Ab only (FITC-goat anti-
mouse IgG). Representative results are shown in Figure 4A and B.
This staining was seen at day 1 after irradiation with 10Gy and
became increasingly stronger on days 2 and 3. Radiation delivered
via Abs binding to the cell surface in the form of
111In-rituximab
produced very similar results (data not shown). Results are shown
with Raji B lymphoma cells, but similar results were obtained with
another B lymphoma cell line, Daudi. Similar staining was
observed with 13 different Abs, all expected to be control, non-
reactive Abs, and all non-reactive with untreated cells. The panel of
Abs tested included conjugates with fluorescein, rhodamine, Alexa
488, and phycoerythrin, and included goat and mouse Abs. Five of
these were F(ab0)2 fragments, demonstrating that the Fc receptor
was not involved, and some of the Abs (from Jackson Immuno-
Research) had been absorbed with human serum proteins. The
initial experiments utilised fixed and permeabilised cells, but the
same experiments were then performed with unfixed cells to
investigate cell surface staining. Results with the unfixed cells were
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Figure 2 Necrotic cells lose mitochondrial membrane potential (MMP),
assayed by JC-1 staining, but can be distinguished from apoptotic cells by
inclusion of Sytox green. Jurkat or Ramos cells were stained with JC-1 only
(left graphs) or with JC-1 plus Sytox green (right graphs), which is a nuclear
stain selective for dead cells. (A, B) Untreated Jurkat cells. (C, D) Jurkat
cells treated overnight with 100mM etoposide. Note that the apoptotic
cells include two distinct populations, which can be considered early and
late apoptotic cells based on the gradual loss of red staining. (E, F)
Untreated Ramos cells. (G, H) Ramos cells treated with 20nM paclitaxel
overnight. (I, J) Jurkat cells killed by heating at 561C for 45min and
examined immediately after killing. Regions R1, R2, and R3 indicated in (A)
represent the normal, apoptotic, and lysed cells, respectively, after staining
with JC-1 plus Sytox green. Note that these regions are slightly different,
but similar for the two cells lines.
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sessentially the same as with the fixed and permeabilised cells
(Figure 4C and D), indicating that the staining was of the cell
surface. Staining was virtually identical whether the Ab incubation
was at room temperature or 41C, demonstrating that cell
metabolism was not required for this staining to occur. The
radiation dose used in these experiments kills approximately
99.9% of the cells, but at these relatively early time points, out to 3
days, the cells were essentially 100% viable, although enlarged, and
there were no morphological abnormalities observed by phase
contrast (ie, the cells did not look apoptotic morphologically). In
addition, these cells did not stain with annexin V and had bright
red mitochondria after staining with JC-1, further demonstrating
that they were not apoptotic. The significance of these results for
our present purpose is that this staining could be misinterpreted as
specific staining of cleaved PARP, cleaved caspase 3, or whatever
other antigen was targeted, if non-reactive control Abs were not
tested. Although it can be argued (and it is true) that such control
Abs should always be tested, in reality they are sometimes omitted,
as discussed further below. The explanation for this nonspecific
staining of irradiated cells is under investigation. It seems likely
to be related in part to the increase in the size of the cells after
irradiation. Figure 4 E and F show a plot of forward scatter vs green
fluorescence for control cells (C) or irradiated cells (D). The
irradiated cells are considerably larger (as indicated by forward
scatter) and for both samples, the larger cells have more
fluorescence than the smaller cells. By comparing these two
graphs, it is evident that the level of nonspecific fluorescence is
primarily dependent on the size of the cell. In conclusion,
irradiated cells have much higher nonspecific Ab binding than
control cells, which means that untreated cells cannot be used as a
specificity control in experiments of this type.
Cell aggregation by Abs
Binding of Abs to the cells surface has been frequently reported to
induce apoptosis of lymphoma cells, especially if the Ab is
crosslinked with a secondary Ab (Truman et al, 1997; Shan et al,
1998; Nagy et al, 2002; Carlo-Stella et al, 2006). In performing such
experiments, we noted that Ab binding sometimes induced
extensive aggregation of the cells. This is shown for Raji cells
treated with L243 (anti-HLA-DR) at 30mgml
 1 (Figure 5). These
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Figure 3 Annexin V-positive, propidium iodide (PI)- negative cells, and
subcellular fragments after 4h treatment of Jurkat cells with 4mM
camptothecin. (A) Representative photographs showing ‘apoptotic cells’
of varying sizes and a lysed cell (a) stained with both annexin V and PI for
comparison. The ‘apoptotic cells’ range in size from 12.2mM (b) to 3.8mM
(k). The diameter of normal Jurkat cells is 11.071.0mM, so slightly smaller
than the cell shown in (b). Bar¼10.0mM. FACS dot plots show control cells
(B) or CTT-treated cells (C) stained with annexin V (green) and propidium
iodide (red). The marked regions R1, R2, and R3 include healthy, apoptotic,
and lysed cells, respectively, and apoptotic cells are coloured green, normal
cells red, and lysed cells black. (D) The same cells as in (C), with the same
colouring, are shown in a plot of forward scatter vs. green fluorescence.
Note that the ‘apoptotic cells’ (green) are smaller then normal cells (red),
and of varying size, so there is no obvious separation between apoptotic
cells and subcellular fragments. (E) Similar to (D), but a plot of forward
scatter vs side scatter, further showing the overlap between normal cells,
apoptotic cells, and subcellular fragments.
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Figure 4 Nonspecific staining of irradiated cells with fluorochrome-
conjugated secondary Abs. Raji cells were irradiated with 10Gy from a
137Cs irradiator, then washed and cultured in tissue culture medium for 1–
3 days. At day 1 (A) or day 2 (B), cells were fixed and permeabilised, then
stained by the procedure used for staining with anti-cleaved PARP (but
without the primary Ab), using FITC-goat anti-mouse IgG. At day 2 (C)o r
day 3 (D) viable unfixed cells were stained with FITC-normal goat IgG.
Results are shown for untreated cells (unfilled curve) and irradiated cells
(filled curve). (E, F) Dot plots of forward scatter vs green fluorescence for
the same two samples shown in (B): (E), control untreated cells; (F), cells 2
days after irradiation. Note that the irradiated cells are considerably larger
and that fluorescence is correlated with cell size (as indicated by forward
scatter).
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saggregates were very large and very tight, such that it was
impossible to disperse the cells into a single-cell suspension. That
is, shaking or repipetting the aggregated cells only partially
dispersed the aggregates, leaving clusters of 10 cells or more. Very
hard repipetting did gradually disperse the aggregates, but
appeared to kill many of the cells, especially those that were
released as single cells, as detected by trypan blue staining. The
remaining aggregates often had dead cells at the edges of the
aggregates, while otherwise the aggregates remained mostly viable.
These results suggested that the mechanical trauma required to
extract cells from the clusters was responsible for the death of the
cells. Because of the large aggregates, it was impossible to count
the cells with an acceptable level of accuracy, and it was also
impossible to test the cells for apoptosis by most of the methods
that are usually employed. The aggregates started to develop
within 2h and became increasingly large and dense over the next
24h. Initial experiments utilised L243 at 30mgml
 1, following
Nagy et al (2002), but a range of Ab concentrations were tested.
Judging microscopically by the extent of aggregation, 3mgml
 1
had the same effect as 30mgml
 1,3 0 n g m l
 1 produced slight
aggregation, and 300ngml
 1 had an intermediate effect.
One method of evaluating the viability of cells within clusters is
a long-term proliferation assay (Griffiths et al, 1999), which simply
consists of cell counts at various times, out to 21 days. With this
assay, the cells are cultured until the clusters disperse, due
presumably to the gradual catabolism of the bound Ab. Unbound
Ab was removed after 1 day by washing the cells, which could be
performed (without damaging the cells) by transferring the
aggregates gently with a truncated pipettor tip (having a large
opening). Accurate cell counts could not be obtained until clusters
became small, which required 8 days; 11 days were required for
Ab-induced aggregation to be totally eliminated. Calculation of the
apparent fraction surviving from the growth curves suggested that
the fraction surviving was only 0.168. However, this calculation
is based on the growth rate. As there was no any indication of
significant cell death (cells stained with trypan blue or cells that
looked apoptotic), the most likely explanation for these data is that
the aggregated cells multiplied more slowly than untreated cells,
due perhaps to physical constraints. The calculated doubling time
was 1.37 days for Ab-treated cell and 0.83 days for control cells.
Although the explanation for the decreased growth rate is
uncertain, it is reasonable to conclude that a decreased growth
rate does not necessarily reflect either apoptosis or any other type
of cell death.
The aggregation of cells by Abs and the tightness of the
aggregates was dependent on the particular cell line as well as on
the Abs used. RL cells were aggregated by L243, but did not
develop the extremely tight undissociable aggregates that formed
with Raji cells. The anti-CD20 Ab 1F5 was also tested, alone or with
a secondary Ab, because this is a model that has been used by
other laboratories. Using the model described by Shan et al (1998),
Raji cells incubated with 1F5 plus a secondary Ab (but not with
1F5 alone) developed tight aggregates that could not be entirely
dispersed by standard repipetting, and harsh pipetting appeared to
cause significant levels of cell death. These clusters, however, were
much smaller and less tight than the clusters induced by L243.
With other cell lines, namely Ramos, Daudi, RL, and SU-DHL-6,
under the same conditions, there was some Ab-induced clustering,
but dispersal of the clusters produced a high-viability single-cell
suspension with no increase in the number of dead cells. Thus,
based on the limited studies that have been performed, it appears
that Raji is more susceptible than some other cell lines to tight
Ab-induced clustering.
DISCUSSION
The data presented demonstrate five problems with assays that
are widely used to measure apoptosis, which might lead to
misinterpretation of the results. Table 1 provides a synopsis of the
four assays utilised, and their potential problems. The aggregation
problem would interfere with all of these assays. Three of these
problems might be considered technical, in that they relate to the
quality of the experiments performed. The other two, however,
relate to the validity of the assays themselves: that is, the assays
do not distinguish between apoptotic and necrotic cells. This
A
C
B
Figure 5 Tight aggregation of Raji B lymphoma cells by anti-HLA-DR
(L243). (A) Control cells, which form some loose clusters that can be
readily dispersed by pipetting (without loss of viability). Note that there are
also many single cells ( 10 objective, phase contrast). (B) Cells incubated
overnight with L243 at 30mgml
 1. The cells form large, irregular clusters
and there are very few single cells. The cell density seems greater than in
(A) because all of the cells in the well are clustered into the centre of the
well ( 10 objective, brightfield). (C) A higher-power photograph of the
same cells as shown in (B) to better display the tightly aggregated cells
( 40 objective, brightfield). Bar¼ 200mM.
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sdifference is not critical in some cases, in which the main question
is whether cells are dead or viable. In such a case, this problem
may be considered mainly semantic, as these two assays do show
unequivocally that cells are dead. However, in cases in which the
focus is on the mechanism of cell kill, this factor is fundamental.
What is demonstrated herein, specifically, is that some cells dead
from necrosis may be mistaken for apoptotic cells. Our data relate
only to non-adherent haematological tumours and may not
entirely apply to adherent tumour cells. However, it seems likely
that most of the problems discussed, except for the problem of cell
aggregation, would also apply to adherent cell lines.
The PI method of staining sub-G1 cells was developed using
corticosteroid-treated thymocytes (Nicoletti et al, 1991). With this
cell type, the assay correlated well with other assays for apoptosis,
and cells killed by non-apoptotic mechanisms were negative.
However, the cells that had been killed by other mechanisms were
not maintained and examined for several days, as performed
herein, and may have developed a sub-G1 population at later time
points. In addition, thymocytes may behave differently from
tumour cells in this assay. The use of a 1–2-day incubation period,
as performed here, is relevant to most toxicity studies. It is not
surprising that necrotic cells gradually disintegrate, slowly losing
DNA. It might be argued that in our experiments apoptosis was
activated during the 45min heat treatment (at 561C), which was
the time interval required to lyse all of the cells (assessed by trypan
blue staining). However, it is unlikely that apoptosis could proceed
at 561C. Mild heat treatment, with a peak at 431C, does induce
apoptosis in haematological cell lines, but temperatures above
471C induce only necrosis (O’Neill et al, 1998). Also, as freshly
heat-killed cells did not have a sub-G1 cell population, this
hypothesis would require that apoptotic processes continued to
function after the cells lysed, which is also unlikely. Moreover, this
argument would not apply to cells killed by the other two methods
used. Killing with digitonin required only a 5min incubation to
produce a significant population of sub-G1 cells. Freeze–thawing
killed cells within seconds, if we do not count the time for which
the cells were frozen.
The use of assays for MMP to detect apoptosis was based on the
finding that apoptotic pathways induce leakage of components
from inside the mitochondria, which play a major role in the
further amplification of apoptotic pathways (Green, 2003; Henry-
Mowatt et al, 2004). Although such assays have been widely used
(Darzynkiewicz et al, 2001; Chan et al, 2003; Jazirehi et al, 2003;
Carlo-Stella et al, 2006), there has been insufficient consideration
of the fact that necrotic cells also lose their MMP. There were a
few previous reports that cells killed by any mechanism have non-
functional mitochondria (Darzynkiewicz et al, 1994; Lemasters
et al, 1998). We demonstrated that necrotic cells killed by heating
or freeze–thawing lost MMP, demonstrating that this assay, like
the PI assay, cannot identify apoptotic cells. However, we also
demonstrated that if determination of cell membrane integrity is
combined with an assay of mitochondrial function, then it is
possible to reliably distinguish between viable, apoptotic and lysed
cells. This was demonstrated with two model systems: etoposide-
treated Jurkat cells and paclitaxel-treated Ramos cells. Inasmuch as
paclitaxel treatment of Ramos cells was reported to be unable to
induce apoptosis in the absence of an anti-CD20 Ab (Jazirehi et al,
2003), we note that in our studies this was not the case. We have no
explanation for this discrepancy, but note that the cell density was
much greater in the experiments of Jazirehi et al (2003) than in our
experiments. The presence of apoptotic cells after treatment of
Ramos with paclitaxel was confirmed by microscopic observation
(cells with condensed, often fragmented nuclei unstained by trypan
blue)by annexin V plus PI staining, and by immunofluorescent
staining with an Ab to cleaved PARP (unpublished data). The
modified JC-1 assay may be widely applicable, as it is a simple and
rapid assay that enumerates apoptotic, lysed, and normal cells.
The other three problems described here relate to the quality of
the assays performed rather than the validity of the assays
themselves. However, these problems can also lead to over-
estimation of the role of apoptosis in the killing of cells. Because
dead cells gradually disintegrate, producing subcellular fragments
of various sizes, because apoptotic cells are sometimes condensed,
and because apoptotic cells often disintegrate in the form of
apoptotic bodies (Kerr et al, 1972), the calculation of percentage
apoptosis is complicated by the presence of subcellular fragments.
Moreover, we recently showed that small annexin V-positive
vesicles are shed from viable cells in the absence of significant
levels of apoptosis or cell death (Michel et al, 2006). Although
subcellular fragments can be gated out by FACS analysis, the
problem is where to set the gate, since, as shown here, the
subcellular fragments form a continuum of sizes, without any clear
distinction between apoptotic cells and subcellular fragments. Our
standard cutoff, half the size of the smallest normal cell, seems
reasonable, but it should be recognised that it is not entirely
satisfactory. As the size of normal cells covers an approximately
twofold range, and as damaged cells are frequently enlarged
(especially irradiated cells), this cutoff size will be less than one-
fourth the size of some viable cells. Therefore, it is possible that
one affected cell can fragment into multiple ‘apoptotic cells’, which
would distort the percentages calculated. Thus, annexin V-positive,
PI-negative objects can be accepted as apoptotic cells only if those
objects are shown to be approximately cell-size. As phospholipid
asymmetry is maintained by an energy-dependent enzyme
(Verhoven et al, 1995), it is likely that it would be lost in any
type of subcellular fragment. If these fragments do not contain
DNA or have an intact membrane, they will not stain with PI and
might be recorded as apoptotic cells. In the particular experiment
shown, the calculated % apoptosis was altered by 36% by changing
the size threshold, which might be considered a relatively minor
difference (though not insignificant). But the percentage of
annexin V-positive subcellular fragments could be much higher
Table 1 Synopsis of problems with assays used to detect apoptosis
Method References
a Potential problem
PI staining (Shan et al, 1998; Chan et al, 2003; Jazirehi et al,
2003)
Does not distinguish between necrotic and
apoptotic cells.
Staining for mitochondrial membrane potential (Darzynkiewicz et al, 2001; Chan et al, 2003;
Jazirehi et al, 2003; Carlo-Stella et al, 2006)
Does not distinguish between necrotic and
apoptotic cells (unless JC-1 is combined with Sytox
green).
Ab detection of cleaved PARP, caspase 3, or other
markers
(Dai and Krantz, 1999; Darzynkiewicz et al, 2001;
Jazirehi et al, 2003)
Nonspecific staining may be increased. Must
include negative control Ab.
Annexin V staining (Shan et al, 2000; Darzynkiewicz et al, 2001; Cragg
and Glennie, 2004)
Subcellular fragments may obscure results. Must
monitor size of objects counted in the FACS.
b
Abbreviations: Ab, antibody; FACS, fluorescence-activated cell sorter; PARP, poly(ADP-ribose) polymerase; PI, propidium iodide.
aReferences cited are examples in which these
methods were used, chosen from a large number of such publications.
bThis problem applies to all assays which are scored with the FACS.
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sin other cases. Published data should include a graph of forward
scatter (as in Figures 3D and E), the size threshold used for
forward scatter, or photographs of representative apoptotic cells,
so that the size of the annexin-stained objects can be evaluated.
It may seem unnecessary to argue for the importance of testing
non-reactive, isotype-matched control Abs, labelled in the same
way as the specific Ab, as a test of specificity, but this is not the
case. Such controls are sometimes lacking or, at least, not
described. This problem is due partly to the fact that some of
the Abs widely used to detect apoptosis are rabbit monoclonal Abs,
for which the required control reagents are not available. For
example, BD Biosciences and Cell Signaling Technology (Beverly,
MA, USA) sell fluorescein-conjugated rabbit monoclonal Abs to
apoptosis-related antigens, but they do not sell a non-reactive
control rabbit Ab conjugated similarly (although they do sell
mouse and rat control Abs). Technical information from these
suppliers and statements from other investigators (Roederer, 2001)
have claimed that isotype-matched control Abs are not required
to prove specificity, and are not a reliable control. However, such
arguments are unconvincing: if a non-reactive Ab produces the
same staining as a specific Ab, then there is no specificity.
Inasmuch as there is a single class of rabbit IgG (Knight et al,
1985), normal rabbit IgG can be used as a control for a rabbit
mAb, but it must be appropriately conjugated. It is sometimes
considered adequate to use untreated cells as a specificity control,
in comparison with cells treated with an agent that induces
apoptosis. However, our data with irradiated cells demonstrate
that such a control is not an adequate proof of specificity. Any cell
that is damaged may potentially have increased nonspecific
binding. Irradiated cells become enlarged and cell enlargement
probably explains part or all of the effect observed. We note that
PARP cleavage is frequently assayed by Western blotting, which
would not be affected by the problem described here, but does not
provide information on individual cells.
The problem of cell aggregation by Ab crosslinking is not a
problem of the apoptosis assays themselves, but it is relevant to
the current study because this is another factor that may lead to
overestimation of the role of apoptosis. This factor appears to have
been overlooked in some previous reports. For example, earlier
studies of the effect of L243 (anti-HLA-DR) on Raji cells (identical
to the model we used), which claimed that apoptosis occurred, did
not mention the dramatic aggregation that occurs (Kostelny et al,
2001; Nagy et al, 2002). One consequence of aggregation, which
we documented, is that it may be impossible to disperse the cells
in tight aggregates without killing the cells. Such death can be
attributed to mechanical stress, as the cells are handled (pipetted,
centrifuged, or resuspended). Whether damage occurs or not
depends on the strength of the crosslinking. Loose aggregates, such
as those that form spontaneously with many B-lymphoma and
B-lymphoblastoid cell lines, are readily dispersed by pipetting or
shaking, with no evident damage to the cells. However, when
crosslinking is strong, as when Raji cells are treated with Ab L243,
it may be impossible to disaggregate the cells without killing them.
Thus, it is not aggregation per se that represents a problem, but
rather the fact that tight aggregates cannot be dispersed without
damaging the cells. The situation is analogous to that of balloons
taped together: the tape itself does not break the balloons, but
trying to separate the balloons will cause them to break. These
considerations apply not only to aggregated cells, but also to cells
attached to a plastic surface via surface-bound Abs (which would
be analogous to balloons taped to a wall), as has been used with
anti-CD20 Abs (Mathas et al, 2000; Cragg and Glennie, 2004). Chan
et al (2003) reported that certain Abs to CD20 were able to induce
apoptosis and that the ability to induce apoptosis was correlated
with the extent of aggregation induced by the Ab; this suggests the
possibility that it was the aggregation itself that was responsible
for some of the effects. One approach to circumvent the effect of
aggregation would be to grow cells in soft agarose, which would
prevent cell aggregation but would allow Ab binding.
A sixth problem with apoptosis assays is the frequent lack of
microscopic observation: many types of errors would be readily
revealed in this way. FACS data alone allow many errors in
interpretation, such as the counting of subcellular fragments as
apoptotic cells. In conclusion, these data demonstrate that some
widely used assays for apoptosis do not actually measure
apoptosis, but instead detect any type of cell death, apoptotic, or
necrotic. This statement is not meant to imply that apoptosis is
not an important mechanism of death in many situations, or that
reliable assays for apoptosis are not available. Annexin V–PI
binding is reliable if the size of the apoptotic cells is described.
Measurement of cleaved caspase 3 or PARP is reliable if specificity
controls are adequate. The modified JC-1 assay, combined with
Sytox green, appears to be reliable. The PI assay for sub-G1 DNA is
not reliable and should not be used. These considerations will be
helpful in understanding the mechanisms by which tumours cells
are killed.
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